Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Tick-Borne Encephalitis Virus Vaccines Contain Non-Structural Protein 1 Antigen and may Elicit NS1-Specific Antibody Responses in Vaccinated Individuals.

Salat J, Mikulasek K, Larralde O, Pokorna Formanova P, Chrdle A, Haviernik J, Elsterova J, Teislerova D, Palus M, Eyer L, Zdrahal Z, Petrik J, Ruzek D.

Vaccines (Basel). 2020 Feb 12;8(1). pii: E81. doi: 10.3390/vaccines8010081.

2.

Could 5'-N and S ProTide analogues work as prodrugs of antiviral agents?

Procházková E, Hřebabecký H, Dejmek M, Šála M, Šmídková M, Tloušťová E, Zborníková E, Eyer L, Růžek D, Nencka R.

Bioorg Med Chem Lett. 2020 Feb 15;30(4):126897. doi: 10.1016/j.bmcl.2019.126897. Epub 2019 Dec 17.

PMID:
31882298
3.

An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice.

Eyer L, Nougairède A, Uhlířová M, Driouich JS, Zouharová D, Valdés JJ, Haviernik J, Gould EA, De Clercq E, de Lamballerie X, Ruzek D.

J Virol. 2019 Jul 30;93(16). pii: e00367-19. doi: 10.1128/JVI.00367-19. Print 2019 Aug 15.

4.

Antiviral Activity of Uridine Derivatives of 2-Deoxy Sugars against Tick-Borne Encephalitis Virus.

Krol E, Wandzik I, Brzuska G, Eyer L, Růžek D, Szewczyk B.

Molecules. 2019 Mar 21;24(6). pii: E1129. doi: 10.3390/molecules24061129.

5.

Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines.

Ruzek D, Avšič Županc T, Borde J, Chrdle A, Eyer L, Karganova G, Kholodilov I, Knap N, Kozlovskaya L, Matveev A, Miller AD, Osolodkin DI, Överby AK, Tikunova N, Tkachev S, Zajkowska J.

Antiviral Res. 2019 Apr;164:23-51. doi: 10.1016/j.antiviral.2019.01.014. Epub 2019 Jan 31. Review.

PMID:
30710567
6.

Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Prevents Death in a Mouse Model of West Nile Virus Infection.

Eyer L, Fojtíková M, Nencka R, Rudolf I, Hubálek Z, Ruzek D.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02093-18. doi: 10.1128/AAC.02093-18. Print 2019 Mar.

7.

Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use.

Salát J, Formanová P, Huňady M, Eyer L, Palus M, Ruzek D.

Vaccine. 2018 Nov 19;36(48):7257-7261. doi: 10.1016/j.vaccine.2018.10.034. Epub 2018 Oct 15.

PMID:
30337175
8.

Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses.

Haviernik J, Štefánik M, Fojtíková M, Kali S, Tordo N, Rudolf I, Hubálek Z, Eyer L, Ruzek D.

Viruses. 2018 Apr 10;10(4). pii: E184. doi: 10.3390/v10040184.

9.

Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.

Eyer L, Nencka R, de Clercq E, Seley-Radtke K, Růžek D.

Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618761299. doi: 10.1177/2040206618761299. Review.

10.

Characterisation of Zika virus infection in primary human astrocytes.

Stefanik M, Formanova P, Bily T, Vancova M, Eyer L, Palus M, Salat J, Braconi CT, Zanotto PMA, Gould EA, Ruzek D.

BMC Neurosci. 2018 Feb 20;19(1):5. doi: 10.1186/s12868-018-0407-2.

11.

Escape of Tick-Borne Flavivirus from 2'-C-Methylated Nucleoside Antivirals Is Mediated by a Single Conservative Mutation in NS5 That Has a Dramatic Effect on Viral Fitness.

Eyer L, Kondo H, Zouharova D, Hirano M, Valdés JJ, Muto M, Kastl T, Kobayashi S, Haviernik J, Igarashi M, Kariwa H, Vaculovicova M, Cerny J, Kizek R, Kröger A, Lienenklaus S, Dejmek M, Nencka R, Palus M, Salat J, De Clercq E, Yoshii K, Ruzek D.

J Virol. 2017 Oct 13;91(21). pii: e01028-17. doi: 10.1128/JVI.01028-17. Print 2017 Nov 1.

12.

Immunoaffinity chromatography combined with tandem mass spectrometry: A new tool for the selective capture and analysis of brassinosteroid plant hormones.

Oklestkova J, Tarkowská D, Eyer L, Elbert T, Marek A, Smržová Z, Novák O, Fránek M, Zhabinskii VN, Strnad M.

Talanta. 2017 Aug 1;170:432-440. doi: 10.1016/j.talanta.2017.04.044. Epub 2017 Apr 18.

PMID:
28501193
13.

Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses.

Eyer L, Zouharová D, Širmarová J, Fojtíková M, Štefánik M, Haviernik J, Nencka R, de Clercq E, Růžek D.

Antiviral Res. 2017 Jun;142:63-67. doi: 10.1016/j.antiviral.2017.03.012. Epub 2017 Mar 21.

PMID:
28336346
14.

An Approach for Zika Virus Inhibition Using Homology Structure of the Envelope Protein.

Fernando S, Fernando T, Stefanik M, Eyer L, Ruzek D.

Mol Biotechnol. 2016 Dec;58(12):801-806.

PMID:
27683255
15.

Structure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus.

Eyer L, Šmídková M, Nencka R, Neča J, Kastl T, Palus M, De Clercq E, Růžek D.

Antiviral Res. 2016 Sep;133:119-29. doi: 10.1016/j.antiviral.2016.07.018. Epub 2016 Jul 28.

PMID:
27476046
16.

2,4-D and IAA Amino Acid Conjugates Show Distinct Metabolism in Arabidopsis.

Eyer L, Vain T, Pařízková B, Oklestkova J, Barbez E, Kozubíková H, Pospíšil T, Wierzbicka R, Kleine-Vehn J, Fránek M, Strnad M, Robert S, Novak O.

PLoS One. 2016 Jul 19;11(7):e0159269. doi: 10.1371/journal.pone.0159269. eCollection 2016.

17.

Nucleoside Inhibitors of Zika Virus.

Eyer L, Nencka R, Huvarová I, Palus M, Joao Alves M, Gould EA, De Clercq E, Růžek D.

J Infect Dis. 2016 Sep 1;214(5):707-11. doi: 10.1093/infdis/jiw226. Epub 2016 May 27.

PMID:
27234417
18.

Antiviral activities of 2,6-diaminopurine-based acyclic nucleoside phosphonates against herpesviruses: In vitro study results with pseudorabies virus (PrV, SuHV-1).

Zouharova D, Lipenska I, Fojtikova M, Kulich P, Neca J, Slany M, Kovarcik K, Turanek-Knotigova P, Hubatka F, Celechovska H, Masek J, Koudelka S, Prochazka L, Eyer L, Plockova J, Bartheldyova E, Miller AD, Ruzek D, Raska M, Janeba Z, Turanek J.

Vet Microbiol. 2016 Feb 29;184:84-93. doi: 10.1016/j.vetmic.2016.01.010. Epub 2016 Jan 18.

PMID:
26854349
19.

Nucleoside inhibitors of tick-borne encephalitis virus.

Eyer L, Valdés JJ, Gil VA, Nencka R, Hřebabecký H, Šála M, Salát J, Černý J, Palus M, De Clercq E, Růžek D.

Antimicrob Agents Chemother. 2015 Sep;59(9):5483-93. doi: 10.1128/AAC.00807-15. Epub 2015 Jun 29.

20.

Electron Tomography Analysis of Tick-Borne Encephalitis Virus Infection in Human Neurons.

Bílý T, Palus M, Eyer L, Elsterová J, Vancová M, Růžek D.

Sci Rep. 2015 Jun 15;5:10745. doi: 10.1038/srep10745.

21.

Development of antibodies for determination of alkylresorcinol metabolites in human urine and elucidation of ELISA cross-reactivity.

Wierzbicka R, Eyer L, Landberg R, Kamal-Eldin A, Franek M.

J Immunol Methods. 2014 Nov;413:12-24. doi: 10.1016/j.jim.2014.07.007. Epub 2014 Jul 24.

PMID:
25066633
22.

[New perspectives of the phage therapy].

Eyer L, Pantůcek R, Růzicková V, Doskar J.

Klin Mikrobiol Infekc Lek. 2007 Dec;13(6):231-5. Review. Czech.

PMID:
18320502
23.

Structural protein analysis of the polyvalent staphylococcal bacteriophage 812.

Eyer L, Pantůcek R, Zdráhal Z, Konecná H, Kaspárek P, Růzicková V, Hernychová L, Preisler J, Doskar J.

Proteomics. 2007 Jan;7(1):64-72.

PMID:
17154272
24.

Investigation of families with two or more mentally defective siblings; clinical observations.

WRIGHT SW, TARJAN G, EYER L.

AMA J Dis Child. 1959 Apr;97(4):445-63. No abstract available.

PMID:
13636700

Supplemental Content

Support Center